Finance

Beta
Lists
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00020
+100.00%
(+0.00010) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCEA...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
59.51K
Volume
5.97K
52-wk high
$0.02
52-wk low
$0.00
Beta
1.68
Shares outstanding
232.36M
No. of employees
7
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
59.51K
Volume
5.97K
52-wk high
$0.02
52-wk low
$0.00
Beta
1.68
Shares outstanding
232.36M
No. of employees
7
News stories
From sources across the web
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc
CEO-
Employees7
Founded2019
Headquarters-
SectorBiotechnology
Websiteoceanbiomedical.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
18.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
682.00K
768.00K
1.75M
940.00K
Operating expense
682.00K
768.00K
1.75M
958.00K
Total operating expenses
682.00K
768.00K
1.75M
958.00K
Operating income
-682.00K
-768.00K
-1.75M
-958.00K
Other non operating income
-15.46M
-3.82M
2.47M
-6.94M
EBT including unusual items
-17.23M
-5.53M
283.00K
-8.24M
EBT excluding unusual items
-17.23M
-5.53M
283.00K
-8.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.23M
-5.53M
283.00K
-8.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-515.00K
-461.00K
-433.00K
-343.00K
Net interest expenses
-515.00K
-461.00K
-433.00K
-343.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer